| Dr John Michael Baten, MD | |
|
120 Stone Creek Blvd Ste 200, Flowood, MS 39232-8210 | |
| (016) 822-2294 | |
| (601) 793-4273 |
| Full Name | Dr John Michael Baten |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 120 Stone Creek Blvd Ste 200, Flowood, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114016144 | NPI | - | NPPES |
| 008759071 | Medicaid | MS |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urogynecology Associates Llc | 5395102727 | 2 |
News Archive
A record number of elderly people are completing living wills to guide end-of-life medical treatments - up from 47 percent in 2000 to 72 percent in 2010 - according to new research from the University of Michigan and the Veterans Affairs Ann Arbor Healthcare System.
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
Individual behavior has a significant effect on preventing a large second wave of COVID-19 infections. In fact, maintaining social distancing and other interventions such as the use of face masks and hand hygiene could remove the need for future lockdowns, according to a modeling study performed by the Barcelona Institute for Global Health, an institution supported by the "la Caixa" Foundation.
The U.N. Human Rights Council adopted a "landmark resolution" acknowledging that "preventable maternal mortality and morbidity" is a human rights issue and that national and international efforts to protect women worldwide should be scaled up, the Hudson Valley Press Online reports. More than 70 U.N. member states cosponsored the resolution, led by Colombia and New Zealand (Hudson Valley Press Online, 6/18).
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
› Verified 2 days ago
| Entity Name | Womens Health Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316036353 PECOS PAC ID: 3678476983 Enrollment ID: O20040202000456 |
News Archive
A record number of elderly people are completing living wills to guide end-of-life medical treatments - up from 47 percent in 2000 to 72 percent in 2010 - according to new research from the University of Michigan and the Veterans Affairs Ann Arbor Healthcare System.
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
Individual behavior has a significant effect on preventing a large second wave of COVID-19 infections. In fact, maintaining social distancing and other interventions such as the use of face masks and hand hygiene could remove the need for future lockdowns, according to a modeling study performed by the Barcelona Institute for Global Health, an institution supported by the "la Caixa" Foundation.
The U.N. Human Rights Council adopted a "landmark resolution" acknowledging that "preventable maternal mortality and morbidity" is a human rights issue and that national and international efforts to protect women worldwide should be scaled up, the Hudson Valley Press Online reports. More than 70 U.N. member states cosponsored the resolution, led by Colombia and New Zealand (Hudson Valley Press Online, 6/18).
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
› Verified 2 days ago
| Entity Name | Urogynecology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649981846 PECOS PAC ID: 5395102727 Enrollment ID: O20230531000216 |
News Archive
A record number of elderly people are completing living wills to guide end-of-life medical treatments - up from 47 percent in 2000 to 72 percent in 2010 - according to new research from the University of Michigan and the Veterans Affairs Ann Arbor Healthcare System.
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
Individual behavior has a significant effect on preventing a large second wave of COVID-19 infections. In fact, maintaining social distancing and other interventions such as the use of face masks and hand hygiene could remove the need for future lockdowns, according to a modeling study performed by the Barcelona Institute for Global Health, an institution supported by the "la Caixa" Foundation.
The U.N. Human Rights Council adopted a "landmark resolution" acknowledging that "preventable maternal mortality and morbidity" is a human rights issue and that national and international efforts to protect women worldwide should be scaled up, the Hudson Valley Press Online reports. More than 70 U.N. member states cosponsored the resolution, led by Colombia and New Zealand (Hudson Valley Press Online, 6/18).
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Michael Baten, MD 120 Stone Creek Blvd Ste 200, Flowood, MS 39232-8210 Ph: (601) 822-2294 | Dr John Michael Baten, MD 120 Stone Creek Blvd Ste 200, Flowood, MS 39232-8210 Ph: (016) 822-2294 |
News Archive
A record number of elderly people are completing living wills to guide end-of-life medical treatments - up from 47 percent in 2000 to 72 percent in 2010 - according to new research from the University of Michigan and the Veterans Affairs Ann Arbor Healthcare System.
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
Individual behavior has a significant effect on preventing a large second wave of COVID-19 infections. In fact, maintaining social distancing and other interventions such as the use of face masks and hand hygiene could remove the need for future lockdowns, according to a modeling study performed by the Barcelona Institute for Global Health, an institution supported by the "la Caixa" Foundation.
The U.N. Human Rights Council adopted a "landmark resolution" acknowledging that "preventable maternal mortality and morbidity" is a human rights issue and that national and international efforts to protect women worldwide should be scaled up, the Hudson Valley Press Online reports. More than 70 U.N. member states cosponsored the resolution, led by Colombia and New Zealand (Hudson Valley Press Online, 6/18).
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
› Verified 2 days ago
Dr. Charles Shannon Carroll, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 291 E Layfair Dr, Flowood, MS 39232 Phone: 601-936-9190 Fax: 601-932-6714 | |
Dr. Joel G Payne Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 291 E Layfair Dr, Flowood, MS 39232 Phone: 601-936-9190 Fax: 601-932-6714 | |
Mrs. Kay Elizabeth Midler, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1050 River Oaks Drive, Suite 200, Flowood, MS 39232 Phone: 601-200-8201 Fax: 601-987-0019 | |
Dr. John W Cook, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 291 E Layfair Dr, Flowood, MS 39232 Phone: 601-936-9190 Fax: 601-932-6714 | |
Dr. Shimeka Lanette Banks, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1307-b Airport Road North, Flowood, MS 39232 Phone: 601-825-7280 | |
Dr. Lindsey Miller Turner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1020 River Oaks Dr Ste 320, Flowood, MS 39232 Phone: 601-936-1400 Fax: 601-936-1416 | |
Dr. Natasha N Hardeman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2506 Lakeland Dr Ste 600, Flowood, MS 39232 Phone: 601-939-1600 Fax: 601-939-1606 |